| Literature DB >> 33328704 |
Cathal O'Leary1, Michael C Soulen1, Susan Shamimi-Noori1.
Abstract
Metastatic liver disease is one of the major causes of cancer-related morbidity and mortality. Locoregional therapies offered by interventional oncologists alleviate cancer-related morbidity and in some cases improve survival. Locoregional therapies are often palliative in nature but occasionally can be used with curative intent. This review will discuss important factors to consider prior to palliative and curative intent treatment of metastatic liver disease with locoregional therapy. These factors include those specific to the tumor, liver function, liver reserve, differences between treatment modalities, and patient-specific considerations. Thieme. All rights reserved.Entities:
Keywords: ablation; hepatic metastases; liver reserve; locoregional therapy; transarterial therapy
Year: 2020 PMID: 33328704 PMCID: PMC7732560 DOI: 10.1055/s-0040-1719189
Source DB: PubMed Journal: Semin Intervent Radiol ISSN: 0739-9529 Impact factor: 1.513